Clinical Trial Update: Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia [Phase 3]

View source ↗

Summary

Phase 3 trial update for DWJ1252 assessing efficacy and safety in functional dyspepsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• DWJ1252

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Functional Dyspepsia | Phase 3 | Status: COMPLETED